This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 15 from Patent US 20110319336
General Information
DRACP ID DRACP01400
Peptide Name Sequence 15 from Patent US 20110319336
Sequence YCDGFYACYMDVGGGKLlLKlLkkLLKlLKKK
Sequence Length 32
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification l=D-Leucine; k=D-Lysine
Chiral Mix
Physicochemical Information
Formula C143H221N33O30S3
Absent amino acids EHINPQRSTW
Common amino acids KL
Mass 353186
Pl 9.66
Basic residues 6
Acidic residues 2
Hydrophobic residues 9
Net charge 4
Boman Index -414
Hydrophobicity 8.13
Aliphatic Index 85.31
Half Life
/
Extinction Coefficient cystines 4595
Absorbance 280nm 148.23
Polar residues 9
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2011/0319336 A1
Patent Title Selective anticancer chimeric peptide.
Other Iinformation Granted Patent Family: 19s / 19ex; Family Jurisdictions: US, JP, EP, WO, CN; Legal Status: Active; Application No: 200913132580; Filed: Dec 3, 2009; Published: Dec 29, 2011; Earliest Priority: Dec 3, 2008; Granted: May 7, 2013
Other Published ID CN102238965A EP2370107A2 WO2010064207A2 WO2010064207A3
This work is licensed under a Creative Commons Attribution 4.0 International License.